These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1291843)

  • 1. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.
    Lagergård T
    Microb Pathog; 1992 Sep; 13(3):203-17. PubMed ID: 1291843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi.
    Campagnari AA; Wild LM; Griffiths GE; Karalus RJ; Wirth MA; Spinola SM
    Infect Immun; 1991 Aug; 59(8):2601-8. PubMed ID: 1855979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies to Haemophilus ducreyi cytotoxin.
    Lagergård T; Purvén M
    Infect Immun; 1993 Apr; 61(4):1589-92. PubMed ID: 8454369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model.
    Wising C; Svensson LA; Ahmed HJ; Sundaeus V; Ahlman K; Jonsson IM; Mölne L; Lagergård T
    Microb Pathog; 2002 Aug; 33(2):49-62. PubMed ID: 12202104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
    Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi.
    Purcell BK; Richardson JA; Radolf JD; Hansen EJ
    J Infect Dis; 1991 Aug; 164(2):359-67. PubMed ID: 1856485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes.
    Ahmed HJ; Johansson C; Svensson LA; Ahlman K; Verdrengh M; Lagergård T
    Infect Immun; 2002 Feb; 70(2):899-908. PubMed ID: 11796625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A humoral immune response confers protection against Haemophilus ducreyi infection.
    Cole LE; Toffer KL; Fulcher RA; San Mateo LR; Orndorff PE; Kawula TH
    Infect Immun; 2003 Dec; 71(12):6971-7. PubMed ID: 14638786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of skin lesions in mice following intradermal inoculation of Haemophilus ducreyi.
    Tuffrey M; Alexander F; Ballard RC; Taylor-Robinson D
    J Exp Pathol (Oxford); 1990 Apr; 71(2):233-44. PubMed ID: 2331407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swine model of Haemophilus ducreyi infection.
    Hobbs MM; San Mateo LR; Orndorff PE; Almond G; Kawula TH
    Infect Immun; 1995 Aug; 63(8):3094-100. PubMed ID: 7622236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid.
    Wising C; Mölne L; Jonsson IM; Ahlman K; Lagergård T
    Microbes Infect; 2005 May; 7(5-6):867-74. PubMed ID: 15876546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible immunity with a pilus preparation booster vaccination in an animal model of Haemophilus ducreyi infection and disease.
    Desjardins M; Filion LG; Robertson S; Cameron DW
    Infect Immun; 1995 May; 63(5):2012-20. PubMed ID: 7729916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus ducreyi, a cytotoxin-producing bacterium.
    Purvén M; Lagergård T
    Infect Immun; 1992 Mar; 60(3):1156-62. PubMed ID: 1541531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid.
    Abeck D; Korting HC
    Acta Derm Venereol Suppl (Stockh); 1992; 174():1-20. PubMed ID: 1636361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune cells are required for cutaneous ulceration in a swine model of chancroid.
    San Mateo LR; Toffer KL; Orndorff PE; Kawula TH
    Infect Immun; 1999 Sep; 67(9):4963-7. PubMed ID: 10456960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid.
    Desjardins M; Filion LG; Robertson S; Kobylinski L; Cameron DW
    Infect Immun; 1996 May; 64(5):1778-88. PubMed ID: 8613391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Haemophilus ducreyi lipooligosaccharide by means of an immunolimulus assay.
    Hansen EJ; Lumbley SR; Saxen H; Kern K; Cope LD; Radolf JD
    J Immunol Methods; 1995 Sep; 185(2):225-35. PubMed ID: 7561133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of Haemophilus ducreyi adherence to and cytotoxin destruction of human epithelial cells.
    Lagergård T; Purvén M; Frisk A
    Microb Pathog; 1993 Jun; 14(6):417-31. PubMed ID: 8412616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of the Skin Pathogen
    Brothwell JA; Griesenauer B; Chen L; Spinola SM
    Front Immunol; 2020; 11():615402. PubMed ID: 33613541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical investigations of genital ulcers caused by Haemophilus ducreyi.
    Abeck D; Freinkel AL; Korting HC; Szeimis RM; Ballard RC
    Int J STD AIDS; 1997 Sep; 8(9):585-8. PubMed ID: 9292349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.